Clinical Research Facilities and Integrating Special Populations

With the support of a dedicated Frontiers Navigator, investigators can develop, initiate, and complete studies using Frontiers-affiliated Clinical and Translational Science Units (CTSUs). These state-of-the-art facilities provide space for researchers to see patients who are enrolled in clinical trials. The Navigator assists investigators with preparing for scientific review, seeking approvals (e.g. IRB review), budget development and fostering needed collaborations. The Navigator guides PIs and study teams through study start-up by assessing feasibility, identifying necessary resources and staff, and linking with other resources such as regulatory experts. The highly trained staff of the CTSUs ensure that participants have a positive experience and that protocols are followed, thereby contributing to better outcomes and successful clinical trials.

Integrating special populations focuses on engaging participants across the lifespan to improve health outcomes. This multi-organizational team includes patients, caregivers, clinicians and scientists.  Another goal of ISP is to improve rare disease health outcomes.  A special population workgroup is available to help advise investigators and link research teams to these groups or individuals.

An Integrating Special Populations pilot is issued once a year.  View the RFA.